Top Markets
#1 TENDIES TENDIES +53.06%
#2 Threshold Network Threshold Network +43.82%
#3 Mubarak Mubarak +26.85%
#4 Akedo Akedo +22.46%
#5 Wrapped Aave Ethereum USDC Wrapped Aave Ethereum USDC +18.00%
#6 OSK OSK +16.18%
#7 MultiversX MultiversX +15.71%
#8 Useless Coin Useless Coin +14.84%
#9 Magma Finance Magma Finance +13.62%
#10 Cash Cat Cash Cat +13.56%
Coin of the day
TENDIES TENDIES
Configurações
Idioma
PORTUGUêS
Moeda
USD
Tema
Neumora Therapeutics, Inc. Common Stock Neumora Therapeutics, Inc. Common Stock

Neumora Therapeutics, Inc. Common Stock

NMRA
Classificação em ações #17181
Neumora Therapeutics, Inc. is a specialized biopharmaceutical company... Neumora Therapeutics, Inc. is a specialized biopharmaceutical company progressing through clinical trials, dedicated to advancing therapies for a range of neurological, psychiatric, and neurodegenerative conditions. Its most advanced candidate, navacaprant (also known as NMRA-140), is a novel, once-daily oral kappa opioid receptor antagonist currently undergoing Phase 3 clinical trials for the management of major depressive disorder. Additionally, NMRA-511 is in Phase 1 studies, targeting agitation experienced by individuals with Alzheimer's-related dementia. Another compound, NMRA-266, is also in Phase 1 clinical development, aimed at addressing schizophrenia and other related neuropsychiatric conditions. Beyond its clinical programs, Neumora maintains a preclinical pipeline featuring several promising candidates: NMRA-NMDA for schizophrenia, NMRA-CK1d (a CK1d inhibitor initiative) for amyotrophic lateral sclerosis (ALS), NMRA-NLRP3 for specific neurodegenerative ailments, and NMRA-GCase for Parkinson's disease. Tracing its origins to a 2019 incorporation, the company, initially known as RBNC Therapeutics, Inc., adopted its current name, Neumora Therapeutics, Inc., in October 2021. Its corporate headquarters are situated in Watertown, Massachusetts.
Preço da ação
$1.40
Valor de mercado
$258.49M
Variação (1 dia)
4.89%
Variação (1 ano)
-19.82%
País
US
Negociar Neumora Therapeutics, Inc. Common Stock (NMRA)

Categoria

Healthcare
Histórico de preços das ações de Neumora Therapeutics, Inc. Common Stock (NMRA)
Preço de fecho mais alto: $1.36 em 2026-09-01

Preço de fecho mais baixo: $12.50 em 2023-09-01
Histórico de preços das ações da Neumora Therapeutics, Inc. Common Stock de 2023 a 2026
Desempenho anual do preço das ações
Ano Desempenho
2026 (TTM) 4.73%
2025 -81.20%
2024 -26.84%
2023 0.00%
Preço das ações de empresas similares ou concorrentes
Empresa Preço da ação Variação 1a% País
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $550.56 37.30%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $1.05K 47.97%
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $122.21 -10.03%
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $146.95 507.48%
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $757.71 8.20%
CH